ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

IMNN Imunon Inc

1.5055
0.0655 (4.55%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Imunon Inc IMNN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0655 4.55% 1.5055 08:31:41
始値 安値 高値 終値 前日終値
1.45 1.3801 1.4754 1.44 1.44
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1821:30GLOBEIMUNON’s IND Application Cleared to Begin Human Testing of..
2024/4/1121:00GLOBEIMUNON Reports Compliance with Nasdaq Listing Requirements
2024/3/2821:00GLOBEIMUNON Reports 2023 Financial Results and Provides Business..
2024/3/2521:30GLOBEIMUNON Receives $1.3 Million from Sale of its New Jersey Net..
2024/3/2206:00GLOBEIMUNON to Hold 2023 Financial Results and Business Update..
2024/3/1321:00GLOBEIMUNON Files IND Application to Begin Human Testing of..
2024/3/1306:00GLOBEIMUNON Announces Leadership Change
2024/2/2922:30GLOBEIndependent Lab Confirms Immunogenicity and Protection with..
2024/2/2722:30GLOBEMemorial Sloan Kettering Cancer Center Now Enrolling..
2024/2/2222:00GLOBEIMNN-101 Preclinical Data in SARS CoV-2 Published in..
2024/2/1006:09EDGAR2Form S-1/A - General form for registration of securities..
2023/12/3006:30EDGAR2Form 8-K - Current report
2023/12/2107:15EDGAR2Form S-1 - General form for registration of securities under..
2023/12/1206:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1206:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/1122:35EDGAR2Form 8-K - Current report
2023/12/1122:30GLOBEIMUNON Appoints Dr. Sebastien Hazard as Chief Medical..
2023/11/1423:00GLOBEIMUNON’s VP of R&D to Present at the Vaccines Summit-2023
2023/11/1422:00GLOBEIMUNON Reports Third Quarter 2023 Financial Results and..
2023/11/0722:30GLOBEIMUNON to Hold Third Quarter 2023 Financial Results and..
2023/10/2321:30GLOBEIMUNON’s Chief Science Officer to Present at the 3rd..
2023/10/1921:30GLOBEIMUNON CEO Dr. Corinne Le Goff to Participate in a Panel..
2023/10/1821:30GLOBEIMUNON Announces First Patient enrolled in Phase 1/2..
2023/10/0621:30GLOBEIMUNON Appoints Dr. Patrick Ott to its Scientific Advisory..
2023/9/2821:30GLOBEIMUNON Reports Interim Progression-Free Survival and Overall..
2023/9/2621:30GLOBEIMUNON Releases Enterprise Video Highlighting the Company’s..
2023/9/1321:30GLOBEIMUNON Reminds Investors of its Virtual R&D Day Tomorrow at..
2023/9/0805:30GLOBEIMUNON to Host Virtual R&D Day on September 14th Beginning..
2023/9/0521:30GLOBEIMUNON to Participate in the H.C. Wainwright Global..
2023/8/2505:05GLOBEIMUNON Enters into CRADA for Preclinical Studies of PlaCCine..
2023/8/1421:30GLOBEIMUNON Expands Scientific Advisory Board with the Addition..
2023/8/1021:00GLOBEIMUNON Reports Second Quarter 2023 Financial Results and..
2023/8/0721:30GLOBEPreclinical Data Showing Strong Immunogenicity and..
2023/8/0321:30GLOBEIMUNON to Hold Second Quarter 2023 Financial Results and..
2023/6/2801:00GLOBEIMUNON Unveils New Manufacturing Capabilities at..
2023/6/2706:00GLOBEImunon Reports Inducement Grants under NASDQ Listing Rule..
2023/6/1221:30GLOBEIMUNON CEO to Discuss Company’s Novel Non-viral DNA Therapy..
2023/6/0821:30GLOBEIMUNON’s CEO Presents Business Overview to Investors and..
2023/5/3021:00GLOBEIMUNON Presents PlaCCine Preclinical Data at the 2023..
2023/5/1121:00GLOBEIMUNON Reports First Quarter 2023 Financial Results and..
2023/5/0421:30GLOBEIMUNON to Hold First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock